DR. DANIEL AARON MOROS, M.D.
Neurology at Maple Ave, Larchmont, NY
License number
New York 135230
Category
Neurology
Type
Neurology
Address
Address
19 Maple Ave, Larchmont, NY 10538
Phone
(914) 834-8464
(914) 833-1040 (Fax)
(914) 833-1040 (Fax)
Personal information
See more information about DANIEL AARON MOROS at radaris.comName
Address
Phone
515 E 85Th St APT 5E, New York, NY 10028
Alexandria, NY
5 98Th St, New York, NY 10029
5 98 At 5Th, New York, NY 10001
50 Iselin Ter, Larchmont, NY 10538
Professional information
Non-Sedating Barbiturate Compounds As Neuroprotective Agents
US Patent:
6756379, Jun 29, 2004
Filed:
Jan 27, 2003
Appl. No.:
10/333957
Inventors:
Daniel A. Moros - Larchmont NY
Barrie Levitt - Mamaroneck NY
Avraham Yacobi - Englewood NJ
Barrie Levitt - Mamaroneck NY
Avraham Yacobi - Englewood NJ
Assignee:
Taro Pharmaceutical Industries Ltd. - Haifa Bay
International Classification:
A61K 31515
US Classification:
514270
Abstract:
Methods of providing neuroprotection are disclosed comprising administering a non-sedative barbiturate compound in an amount sufficient to achieve neuroprotection in a mammalian subject. Preferred compounds are in the family of diphenylbarbituric acid and analogs. Preferred doses for a neuroprotective effect exceed the dosage of a corresponding sedative barbiturate without sedative side-effects such as anesthesia and death.
Non-Sedating Barbiturate Compounds As Neuroprotective Agents
US Patent:
8158639, Apr 17, 2012
Filed:
Apr 13, 2010
Appl. No.:
12/759264
Inventors:
Daniel A. Moros - Larchmont NY, US
Barrie Levitt - Mamaroneck NY, US
Avraham Yacobi - Englewood NJ, US
Barrie Levitt - Mamaroneck NY, US
Avraham Yacobi - Englewood NJ, US
Assignee:
Taro Pharmaceutical Industries Ltd. - Haifa Bay
International Classification:
A61K 31/55, C07D 239/64
US Classification:
514270, 544305
Abstract:
Methods of providing neuroprotection are disclosed comprising administering a non-sedative barbiturate compound in an amount sufficient to achieve neuroprotection in a mammalian subject. Preferred compounds are in the family of diphenylbarbituric acid and analogs. Preferred doses for a neuroprotective effect exceed the dosage of a corresponding sedative barbiturate without sedative side-effects such as anesthesia and death.
Dr. Daniel A Moros, Larchmont NY - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology)
Address:
19 Maple Ave, Larchmont 10538
(914) 834-8464 (Phone), (914) 833-1040 (Fax)
(914) 834-8464 (Phone), (914) 833-1040 (Fax)
Certifications:
Neurology, 1981
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Yale University
Graduated: 1974
Hosp St Raphael
Mount Sinai Hospital
Yale University
Graduated: 1974
Hosp St Raphael
Mount Sinai Hospital
Topical Gel Formulation Comprising Organophosphate Insecticide And Preparation Thereof
US Patent:
2012005, Mar 1, 2012
Filed:
Aug 30, 2011
Appl. No.:
13/220935
Inventors:
Sandhya Goyal - Ryebrook NY, US
Subhas Kundu - Tappan NY, US
Daniel Moros - Larchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NJ, US
Subhas Kundu - Tappan NY, US
Daniel Moros - Larchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NJ, US
Assignee:
Taro Pharmaceuticals North America, Inc. - Grand Cayman
International Classification:
A61K 31/6615, A61P 33/14
US Classification:
514122
Abstract:
The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0.1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present gel pharmaceutical formulation preferably contains malathion and optionally contains isopropyl myristate. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same.
Topical Gel Formulation Comprising Insecticide And Its Preparation Thereof
US Patent:
2006012, Jun 8, 2006
Filed:
Jul 12, 2005
Appl. No.:
11/179924
Inventors:
Sandhya Goyal - Ryebrook NY, US
Subhas Kundus - Tappan NY, US
Daniel Moros - Larchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NJ, US
Subhas Kundus - Tappan NY, US
Daniel Moros - Larchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NJ, US
International Classification:
A01N 65/00, A01N 25/00, A01N 43/04, A01N 55/00, A01N 43/30, A01N 29/04
US Classification:
424405000, 514028000, 514065000, 514063000, 514464000, 514747000
Abstract:
The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0.1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same.
Method Of Treating Movement Disorders Using Barbituric Acid Derivatives
US Patent:
7776871, Aug 17, 2010
Filed:
Feb 16, 2006
Appl. No.:
11/355339
Inventors:
Daniel A. Moros - Larchmont NY, US
Assignee:
Taro Pharmaceutical Industries Ltd. - Haifa Bay
International Classification:
A61K 31/515, C07D 239/62, C07D 239/64
US Classification:
514270, 544305
Abstract:
A method of treating movement disorders comprises administering to a human or animal subject in need of treatment a therapeutically effective amount of at least one compound according to the following formula:.
Stabilizing Compositions For Antibiotics And Methods Of Use
US Patent:
2013023, Sep 12, 2013
Filed:
Apr 30, 2013
Appl. No.:
13/873391
Inventors:
- Grand Cayman, KY
Daniel A. Moros - Larchmont NY, US
Satish Asotra - Brampton, CA
Daniel A. Moros - Larchmont NY, US
Satish Asotra - Brampton, CA
Assignee:
TARO PHARMACEUTICALS NORTH AMERICA, INC. - Grand Cayman
International Classification:
A61K 31/43, A61K 31/424
US Classification:
514192, 51421006
Abstract:
The present invention is directed to improved liquid antibiotic formulations. In some embodiments, the present invention is directed to a composition comprising an antibiotic in a liquid comprising triglycerides, wherein the composition has less than about 5% water (w/v).
Method Of Improving Bioavailability For Non-Sedating Barbiturates
US Patent:
2008013, Jun 5, 2008
Filed:
Nov 14, 2007
Appl. No.:
11/984226
Inventors:
Avraham Yacobi - Englewood NJ, US
Daniel A. Moros - Larchmont NY, US
Derek A. Ganes - Toronto, CA
Daniel A. Moros - Larchmont NY, US
Derek A. Ganes - Toronto, CA
International Classification:
A61K 31/515
US Classification:
514270
Abstract:
Administration of 1,3-dimethoxymethyl-5,5-diphenylbarbituric acid and its related compounds with food increases the bioavailability of these compounds. The ratios (fasting/fed) for geometric mean AUCwere 35.6% (DMMDPB), 36.6% (MMMDPB) and 65.3% (DPB) and the geometric mean Cwere 14.6% (DMMDPB), 31.9% (MMMDPB) and 62.9% (DPB). The cyclic ureides may be administered to a subject before or after ingestion of food within a defined time period.
Process For Preparing Non-Hygroscopic Sodium Valproate Composition
US Patent:
2002014, Oct 3, 2002
Filed:
Jan 24, 2001
Appl. No.:
09/767853
Inventors:
Mohammed Safadi - Nazareth, IL
Maya Barder - Haifa, IL
Yechiel Golander - Haifa, IL
Avraham Yacobi - Englewood NJ, US
Daniel Moros - Larchmont NY, US
Barrie Levitt - Mamaroneck NY, US
Michael Friedman - Jerusalem, IL
Maya Barder - Haifa, IL
Yechiel Golander - Haifa, IL
Avraham Yacobi - Englewood NJ, US
Daniel Moros - Larchmont NY, US
Barrie Levitt - Mamaroneck NY, US
Michael Friedman - Jerusalem, IL
Assignee:
TARO PHARMACEUTICAL INDUCTRIES LTD.
International Classification:
A61K031/19
US Classification:
514/557000
Abstract:
The invention provides a process for preparing a non-hygroscopic, highly stable, oral pharmaceutical composition of a salt of valproic acid. The pharmaceutical composition is prepared by blending ingredients including a hygroscopic salt of valproic acid, carbomer, and a non-hygroscopic additive such as dibasic calcium phosphate. Such a composition forms non-hygroscopic, highly moisture stable solid dosage form.
Ibuprofen Suspension
US Patent:
2004025, Dec 23, 2004
Filed:
Jun 17, 2003
Appl. No.:
10/462998
Inventors:
Shen Gao - Brampton, CA
Daniel Moros - Larchmont NY, US
Maxine Moldenhauer - Acton, CA
Daniel Moros - Larchmont NY, US
Maxine Moldenhauer - Acton, CA
International Classification:
A61K009/00
US Classification:
424/400000
Abstract:
A pharmaceutical suspension for oral administration, comprising a suspension of an effective amount of water insoluble active ingredient in a pharmaceutically acceptable aqueous suspension-stabilizing vehicle.